The Midlands Rare Disease Showcase
Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate.
In today's fast-paced digital world delivering relevant, valuable content that resonates with your target audience is more important than ever.
Getting the right treatment, to the right patient, at the right time is the backbone of market access.
Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.
The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector.
The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting.
The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit whic
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox